SEARCH LISTED COMPANY
ANY AUS OR NZ COMPANY
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
| FROM | TO | |
|---|---|---|
| ASSOCIATE GLOBAL PARTNERS LIMITED | 18/11/2022 | |
| CONTANGO ASSET MANAGEMENT LIMITED | 08/09/2016 | 18/11/2022 |
| TYRIAN DIAGNOSTICS LIMITED | 19/11/2008 | 08/09/2016 |
| PROTEOME SYSTEMS LIMITED | 19/11/2008 |
Liberty Place Level 41 161 Castlereagh St Sydney NSW 2000 Locked Bag A14 Sydney South NSW 1235
Tel : 1300 554 474name changed to Contango Asset Management Limited | 08/09/2016 |
we understand that on or about this date the company consolidated its shares 1 for 300 | 06/09/2016 |
The lodged replacement prospectus is for a public offering of 28,643,300 Shares (post Share Consolidation) at an Offer Price of $0.60 each to raise $17,185,980. | 31/08/2016 |
The company advises that it has lodged a replacement prospectus with ASIC dated 31 August 2016 which replaces the original prospectus lodged on 18 August 2016. | 31/08/2016 |
The company releases the results of its meeting. | 25/08/2016 |
The company releases the chairman's address to shareholders at extraordinary general meeting. | 25/08/2016 |
The company announces that it has today lodged its prospectus dated 18 August 2016 with ASIC for a public offer of 28,643,000 Shares (post share consolidation) at an offer price of $0.60 (post share consolidation) each to raise $17,185,980 (Offer). This Prospectus is issued for the purpose of also re-complying with the admission requirements under Chapters 1 and 2 of the ASX Listing Rules following a change to the nature and scale of the Company's activities. | 18/08/2016 |
The company lodges its Preliminary final report for the year ending 30 June 2016. | 18/08/2016 |
Shareholders get 1 share for every 300 they presently hold. | 26/07/2016 |
Notice is given that an extraordinary meeting will be held at 9:00 AM (AEST) on Thursday, 25 August 2016, at the offices of K&L Gates, Level 31, 1 O'Connell Street, Sydney NSW 2000. | 26/07/2016 |
The company lodges its quarterly report. | 18/07/2016 |
The securities of Tyrian Diagnostics Limited will be suspended from quotation immediately, following receipt of an announcement regarding its proposed change of activities. The Company's securities will remain suspended until the Company has complied with Chapters 1 and 2 of the Listing Rules in accordance with Listing Rule 11.1.3. | 24/06/2016 |
the suspension of trading in the securities of Tyrian Diagnostics Limited (the "Company") will be lifted from the commencement of trading on Thursday, 18 November 2010, in accordance with listing rule 17.7, following an announcement by the Company in relation to a capital raising | 18/11/2010 |
the securities of Tyrian Diagnostics Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending an announcement with regard to a proposed capital raising | 17/11/2010 |
name changed from Proteome Systems Limited | 19/11/2008 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Roger Amos | Chairman | 18/06/2007 |
| George Boubouras | Managing Director | 25/08/2016 |
| Andrew Blunden | CFO, Company Secretary | 24/02/2012 |
| Charlie Aitken | Non Exec Director | 25/08/2016 |
| Martin Switzer | Non Exec Director | 25/08/2016 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|
Date of first appointment, title may have changed.
